These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 20708005)

  • 1. Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease.
    Chalasani N; Guo X; Loomba R; Goodarzi MO; Haritunians T; Kwon S; Cui J; Taylor KD; Wilson L; Cummings OW; Chen YD; Rotter JI;
    Gastroenterology; 2010 Nov; 139(5):1567-76, 1576.e1-6. PubMed ID: 20708005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease.
    Rotman Y; Koh C; Zmuda JM; Kleiner DE; Liang TJ;
    Hepatology; 2010 Sep; 52(3):894-903. PubMed ID: 20684021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GWAS-Identified Common Variants With Nonalcoholic Fatty Liver Disease in Chinese Children.
    Shang XR; Song JY; Liu FH; Ma J; Wang HJ
    J Pediatr Gastroenterol Nutr; 2015 May; 60(5):669-74. PubMed ID: 25522307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-SNP analysis of GWAS data identifies pathways associated with nonalcoholic fatty liver disease.
    Chen QR; Braun R; Hu Y; Yan C; Brunt EM; Meerzaman D; Sanyal AJ; Buetow K
    PLoS One; 2013; 8(7):e65982. PubMed ID: 23894275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of FDFT1 polymorphism for fibrosis progression in patients with chronic hepatitis C.
    Stättermayer AF; Rutter K; Beinhardt S; Wrba F; Scherzer TM; Strasser M; Hofer H; Steindl-Munda P; Trauner M; Ferenci P
    Liver Int; 2014 Mar; 34(3):388-95. PubMed ID: 23870067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits.
    Speliotes EK; Yerges-Armstrong LM; Wu J; Hernaez R; Kim LJ; Palmer CD; Gudnason V; Eiriksdottir G; Garcia ME; Launer LJ; Nalls MA; Clark JM; Mitchell BD; Shuldiner AR; Butler JL; Tomas M; Hoffmann U; Hwang SJ; Massaro JM; O'Donnell CJ; Sahani DV; Salomaa V; Schadt EE; Schwartz SM; Siscovick DS; ; ; ; Voight BF; Carr JJ; Feitosa MF; Harris TB; Fox CS; Smith AV; Kao WH; Hirschhorn JN; Borecki IB;
    PLoS Genet; 2011 Mar; 7(3):e1001324. PubMed ID: 21423719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan.
    Kitamoto T; Kitamoto A; Yoneda M; Hyogo H; Ochi H; Nakamura T; Teranishi H; Mizusawa S; Ueno T; Chayama K; Nakajima A; Nakao K; Sekine A; Hotta K
    Hum Genet; 2013 Jul; 132(7):783-92. PubMed ID: 23535911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese.
    Kawaguchi T; Sumida Y; Umemura A; Matsuo K; Takahashi M; Takamura T; Yasui K; Saibara T; Hashimoto E; Kawanaka M; Watanabe S; Kawata S; Imai Y; Kokubo M; Shima T; Park H; Tanaka H; Tajima K; Yamada R; Matsuda F; Okanoue T;
    PLoS One; 2012; 7(6):e38322. PubMed ID: 22719876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-Wide Associations Related to Hepatic Histology in Nonalcoholic Fatty Liver Disease in Hispanic Boys.
    Wattacheril J; Lavine JE; Chalasani NP; Guo X; Kwon S; Schwimmer J; Molleston JP; Loomba R; Brunt EM; Chen YI; Goodarzi MO; Taylor KD; Yates KP; Tonascia J; Rotter JI
    J Pediatr; 2017 Nov; 190():100-107.e2. PubMed ID: 28918882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease.
    Hotta K; Yoneda M; Hyogo H; Ochi H; Mizusawa S; Ueno T; Chayama K; Nakajima A; Nakao K; Sekine A
    BMC Med Genet; 2010 Dec; 11():172. PubMed ID: 21176169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism in the farnesyl diphosphate farnesyl transferase 1 gene and nonalcoholic fatty liver disease severity.
    Ballestri S; Day CP; Daly AK
    Gastroenterology; 2011 May; 140(5):1694-5. PubMed ID: 21439984
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetic Variants Associated With Obesity and Insulin Resistance in Hispanic Boys With Nonalcoholic Fatty Liver Disease.
    Rausch JC; Lavine JE; Chalasani N; Guo X; Kwon S; Schwimmer JB; Molleston JP; Loomba R; Brunt EM; Chen YI; Goodarzi MO; Taylor KD; Yates KP; Rotter JI;
    J Pediatr Gastroenterol Nutr; 2018 May; 66(5):789-796. PubMed ID: 29470286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pooled genetic analysis in ultrasound measured non-alcoholic fatty liver disease in Indian subjects: A pilot study.
    Kanth VV; Sasikala M; Rao PN; Steffie Avanthi U; Rao KR; Nageshwar Reddy D
    World J Hepatol; 2014 Jun; 6(6):435-42. PubMed ID: 25018854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network.
    Brunt EM; Kleiner DE; Wilson LA; Unalp A; Behling CE; Lavine JE; Neuschwander-Tetri BA;
    Hepatology; 2009 Mar; 49(3):809-20. PubMed ID: 19142989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GWAS and enrichment analyses of non-alcoholic fatty liver disease identify new trait-associated genes and pathways across eMERGE Network.
    Namjou B; Lingren T; Huang Y; Parameswaran S; Cobb BL; Stanaway IB; Connolly JJ; Mentch FD; Benoit B; Niu X; Wei WQ; Carroll RJ; Pacheco JA; Harley ITW; Divanovic S; Carrell DS; Larson EB; Carey DJ; Verma S; Ritchie MD; Gharavi AG; Murphy S; Williams MS; Crosslin DR; Jarvik GP; Kullo IJ; Hakonarson H; Li R; ; Xanthakos SA; Harley JB
    BMC Med; 2019 Jul; 17(1):135. PubMed ID: 31311600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease.
    Patton HM; Yates K; Unalp-Arida A; Behling CA; Huang TT; Rosenthal P; Sanyal AJ; Schwimmer JB; Lavine JE
    Am J Gastroenterol; 2010 Sep; 105(9):2093-102. PubMed ID: 20372110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease risk and histologic severity are associated with genetic polymorphisms in children.
    Goyal NP; Rosenthal SB; Nasamran C; Behling CA; Angeles JE; Fishbein MH; Harlow KE; Jain AK; Molleston JP; Newton KP; Ugalde-Nicalo P; Xanthankos SA; Yates K; Schork NJ; Fisch KM; Schwimmer JB;
    Hepatology; 2023 Jan; 77(1):197-212. PubMed ID: 35560106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms in nonalcoholic fatty liver disease: a study in Brazilian patients.
    Domenici FA; Brochado MJ; Martinelli Ade L; Zucoloto S; da Cunha SF; Vannucchi H
    Gene; 2013 Oct; 529(2):326-31. PubMed ID: 23891824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between resistin +299A/A genotype and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus.
    Zhang LY; Jin YJ; Jin QS; Lin LY; Zhang DD; Kong LL
    Gene; 2013 Oct; 529(2):340-4. PubMed ID: 23954219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.